REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/11/2025
Voltar para busca
Dado oficial do USPTO
XYDRII
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
11/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
16/03/2020
Data de registro
10/11/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/11/2020
Última transação
11/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
77
Localização do titular
IE
Examinador
SCLEIDOROVICH,JOANNA YAEL
Unidade examinadora
O10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Bausch + Lomb Ireland Limited
NOVARTIS AG
Representantes
Nancy L. Rowe Bausch + Lomb
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; all of the foregoing excluding pharmaceutical preparations for the treatment or prevention of neurological disorderssleep disorderscentral nervous system
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
CHLD
CHANGE OF OWNER RECEIVED FROM IB
10/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/03/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
17/03/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/03/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/03/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
17/03/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
17/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
08/01/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/12/2020
FIMP
FINAL DISPOSITION PROCESSED
17/12/2020
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
10/12/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
10/11/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
08/10/2020
APET
ASSIGNED TO PETITION STAFF
06/10/2020
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/09/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
18/08/2020
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
30/07/2020
PUBO
PUBLISHED FOR OPPOSITION
30/06/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
29/06/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
29/06/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
29/06/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/06/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/06/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
29/06/2020
NPUB
NOTICE OF PUBLICATION
10/06/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/05/2020
DOCK
ASSIGNED TO EXAMINER
27/05/2020
MAFR
APPLICATION FILING RECEIPT MAILED
15/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/05/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/05/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace XYDRII ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.